Discontinuation report BETOPTIC S

Last updated on 2023-01-19 History
Report ID 170389
Drug Identification Number 01908448
Brand name BETOPTIC S
Common or Proper name BETOPTIC S 0.25% SUSP.
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) BETAXOLOL
Strength(s) 0.25%
Dosage form(s) SUSPENSION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 10ML
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-11-30
Actual discontinuation date 2022-12-29
Remaining supply date 2023-07-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Betoptic S 0.25% Susp. 5mL will continue to be available.
Health Canada comments
Tier 3 Status No
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2023-01-19 French Compare
v9 2023-01-19 English Compare
v8 2022-09-29 French Compare
v7 2022-09-29 English Compare
v6 2022-09-28 French Compare
v5 2022-09-28 English Compare
v4 2022-09-28 French Compare
v3 2022-09-28 English Compare
v2 2022-09-28 English Compare
v1 2022-09-28 English Compare

Showing 1 to 10 of 10